openPR Logo
Press release

Future of Glycated Albumin Assay Market: Trends, Revenue Insights & Competitive Analysis | Biocompare, EFK Diagnostics, Biomatik, Weldon Biotech India Private Limited, Beijing Strong Biotechnologies Inc

11-06-2025 01:02 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Glycated Albumin Assay Market

Glycated Albumin Assay Market

Glycated Albumin Assay market size reached US$470.79 Million in 2024 from US$434.85 Million in 2023 and is expected to reach US$962.12 Million by 2033, growing at a CAGR of 8.15% during the forecast period 2025-2033.

DataM Intelligence has released its latest report on the "Glycated Albumin Assay Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.

According to the International Diabetes Federation, approximately 589 million adults aged 20-79 were living with diabetes in 2024, with this number projected to increase to around 853 million by 2050. Additionally, a significant portion remains undiagnosed, with an estimated 252 million adults unaware of their condition.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/glycated-albumin-assay-market?kb

Key Market Highlights (Rephrased):

North America leads the Glycated Albumin Assay market, capturing the largest revenue share of 38.54% in 2024.

The Asia Pacific region is the fastest-growing market, expected to register a CAGR of 10.27% during the forecast period.

By application type, the type 2 diabetes segment dominated the market with a 48.84% revenue share in 2024

Key Player:

Asahi Kasei Pharma Corporation, Hzymes Biotechnology Co., Ltd., DxGen Corp., Abbexa Ltd., Biocompare, EFK Diagnostics, Biomatik, Weldon Biotech India Private Limited, Beijing Strong Biotechnologies Inc., Diazyme Laboratories Inc

United States: Recent Industry Developments - Glycated Albumin Assay

✅ October 2025: Diagnostic firms introduced point-of-care glycated albumin testing kits for diabetes monitoring.
✅ September 2025: Clinical labs integrated GA assays alongside HbA1c for improved glycemic assessment.
✅ August 2025: FDA cleared automated analyzers enhancing test accuracy and throughput.

Japan: Recent Industry Developments
✅ October 2025: Japanese researchers published new reference ranges for glycated albumin in diabetic populations.
✅ September 2025: Hospitals adopted GA assays for routine checkups in metabolic clinics.
✅ August 2025: Instrument manufacturers upgraded reagent stability and assay precision standards.

Forecast Projection:

The global Glycated Albumin Assay market is set to witness strong growth from 2025 to 2032. After maintaining steady momentum in 2024, the market is expected to accelerate as key industry players implement strategic initiatives to boost adoption. Companies that adapt to these emerging trends will be well-positioned to capture new opportunities and enhance their revenue potential throughout the forecast period.

Market Intelligence Research Process:

The Glycated Albumin Assay Market Report by DataM Intelligence offers a comprehensive analysis built on a mix of primary and secondary research. It explores key factors driving the industry, including government policies, market trends, competitive landscape, technological advancements, and upcoming innovations. This in-depth study uncovers both growth opportunities and potential challenges, helping businesses navigate market fluctuations and make data-driven decisions for sustainable success.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=glycated-albumin-assay-market?kb

Key Segments:

By Application: (Prediabetes, Type 1 Diabetes, Type 2 Diabetes)

By End-User: (Hospital and Diabetes Care Centers, Diagnos, tic Laboratories, Other End Users)

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/glycated-albumin-assay-market?kb

Latest M&A

Lifecycle BioSciences acquired Everest Biotech in 2025 to enhance antibody-based glycated albumin assay offerings and expand R&D capabilities.​

Diazyme Laboratories partnered with Carolina Liquid Chemistries to advance enzyme- and immunoassay-based glycated albumin reagents and testing platforms.​

Key players including Asahi Kasei, Lucica, and Weldonbiotech continue strategic collaborations to innovate and increase market penetration.​

Investment trends focus on expanding point-of-care testing and AI-driven assay development for diabetic care centers and hospitals.

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/glycated-albumin-assay-market?kb

Latest FDA Approvals

The FDA granted approval in 2025 to several glycated albumin assays used in diabetes management, with ongoing expansions in approved indications for diabetic nephropathy and chronic kidney disease.​

Novel glycated albumin assay kits with enhanced analytic performance and scalability have received regulatory clearance for clinical laboratories and point-of-care settings.​

Reimbursement

Despite clinical benefits, inconsistent reimbursement and lack of uniform coverage policies for glycated albumin assays limit widespread adoption, particularly outside the US and Europe.​

Medicare and private insurers provide limited coverage compared to HbA1c, impacting test utilization rates and investment in advanced assay platforms.​

Efforts to include glycated albumin in standard diabetes management guidelines and payer frameworks are ongoing to improve reimbursement and patient access.

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Future of Glycated Albumin Assay Market: Trends, Revenue Insights & Competitive Analysis | Biocompare, EFK Diagnostics, Biomatik, Weldon Biotech India Private Limited, Beijing Strong Biotechnologies Inc here

News-ID: 4257360 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

United States Induction Motor Market 2031 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Induction Motor Market 2031 | Growth Drivers, Trends & Market Fore …
Induction Motor Market size was worth US$ 20.36 billion in 2023 and is estimated to reach US$ 33.66 billion by 2031, growing at a CAGR of 6.49% during the forecast period (2024-2031). Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/induction-motor-market?kb List of Top Key Player: ABB Ltd., Ametek, Emerson Electric, Siemens AG, Brook Crompton, Danaher Corporation, Johnson Electric Holdings, Regal Beloit, WEG Electric Corp.
Digital Therapeutics Market Set for Explosive Growth to USD 39.52 Billion by 2033, Led by North America's 42% Market Share | DataM Intelligence
Digital Therapeutics Market Set for Explosive Growth to USD 39.52 Billion by 203 …
The Global Digital Therapeutics Market size reached USD 6.84 billion in 2024 and is expected to reach USD 39.52 billion by 2033, growing at a CAGR of 21.6% during the forecast period 2025-2033. Market growth is driven by the rising prevalence of chronic diseases like diabetes and mental health disorders, increasing smartphone penetration, and growing patient demand for personalized, app-based interventions. Advancements in AI and machine learning for behavior change, expanding
United States Contrast Media Injectors Market: Real-Time Market Trends & Competitive Landscape
United States Contrast Media Injectors Market: Real-Time Market Trends & Competi …
DataM Intelligence unveils its latest report on the "Contrast Media Injectors Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies
United States Real Time Location System (RTLS) Market Analysis 2026: Growth Drivers, Key Developments, Market Growth, Future Insights, Investment
United States Real Time Location System (RTLS) Market Analysis 2026: Growth Driv …
Real Time Location System (RTLS) Market is expected to grow at a CAGR of 18% during the forecasting period (2022-2029). Request a Premium Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://www.datamintelligence.com/download-sample/real-time-location-system-market?kb United States: Recent Industry Developments ✅ December 2025: Major healthcare systems expanded RTLS deployments to enhance patient tracking, asset utilization, and workflow efficiency. ✅ November 2025: Leading tech providers integrated AI‐driven analytics into RTLS platforms to deliver predictive

All 5 Releases


More Releases for Glycated

Glycated Haemoglobin Testing Equipment Market Size 2024 to 2031.
Market Overview and Report Coverage Glycated Haemoglobin Testing Equipment is used to measure the level of glycated hemoglobin in the blood, which is a crucial indicator for managing diabetes. The market for glycated haemoglobin testing equipment is expected to witness significant growth in the coming years, with a projected CAGR of 8.60% during the forecasted period. The increasing prevalence of diabetes worldwide, coupled with the rising awareness about the
Glycated Hemoglobin Testing Market : Lucrative Opportunities
Organizations fabricating basic diagnostic gadgets are concentrating on encouraging items for viable tests. The utilization of glycated hemoglobin during detection of diabetes illness, mellitus keeps on picking up pace, making an enduring interest for glycated hemoglobin testing. The current report provide details regarding the worldwide glycated hemoglobin testing market. It conveys a figured point of view towards developing interest regarding these diagnosis in detecting of predominant issue, for example, diabetes.
Glycated Albumin Market
Market players and various research organisations are engaged in developing novel diagnostic tests using glycated albumin in order to meet increasing demand from end-use industries. For instance, in 2016, according to a study published in journal Nephrology Dialysis Transplantation reported that glycated albumin might provide a valuable alternative for predicting mortality in diabetic patients on hemodialysis. Furthermore, leading players in the market are focused on new product launches and its
Glycated Albumin Market - Size, Share, Trends, and Forecast
Global Glycated Albumin Market, by Product Type (Human Glycated Albumin and Animal Glycated Albumin), by Application (Diagnosis (Prediabetes, Type 1 Diabetes, and Type 2 Diabetes)) and Research), by End User (Hospitals/Clinics, Diagnostic Centers, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ XX Mn in 2017 and is projected to exhibit a CAGR of XX% over the
Global Glycated Albumin Market 2017 : Exocell, BSBE, Medicalsystem, DIAZYME
Glycated Albumin A market study based on the " Glycated Albumin Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Glycated Albumin Market 2017’. The research report analyses the historical as well as present performance of the worldwide Glycated Albumin industry, and makes predictions on the future status of Glycated Albumin market on the basis of this analysis. Get Free Sample Copy of Report Here
Global Glycated Haemoglobin Testing Market
The Glycated Haemoglobin Testing Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in